Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Hunault

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Haematologica|January 19, 2019
<i>DNMT3A</i> mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemiaJonathan Bond, Aurore Touzart, Stéphane Leprêtre, et al.
Blood|April 23, 2020
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 studyCorentin Orvain, Marie Balsat, Emmanuelle Tavernier, et al.
Bone Marrow Transplantation|October 13, 2020
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMTLeyre Bento, Ariane Boumendil, Hervé Finel, et al.
Blood|March 29, 2003
Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemiaEric Solary, Bernard Drenou, Lydia Campos, et al.
Leukemia & Lymphoma|April 5, 2018
Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phaseLise-Marie Mollard, Aurélie Chauveau, Françoise Boyer-Perrard, et al.
British Journal of Haematology|June 19, 2013
Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-HématologiqueMichael Darmon, François Vincent, Laurent Camous, et al.
American Journal of Hematology|March 25, 2023
Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scoresAmélie Bachelot, Anne Bouvier, Jérémie Riou, et al.
Haematologica|October 26, 2010
A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 studyMathilde Hunault-Berger, Thibaut Leguay, Xavier Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMSArnaud Pigneux, Jean-Luc Harousseau, Francis Witz, et al.
Journal of the American Academy of Dermatology|February 10, 2019
Abnormal T-cell phenotype in episodic angioedema with hypereosinophilia (Gleich syndrome): Frequency, clinical implication, and prognosisNoémie Abisror, Arsène Mekinian, Agnès Dechartres, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Haematologica|January 19, 2019
<i>DNMT3A</i> mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemiaJonathan Bond, Aurore Touzart, Stéphane Leprêtre, et al.
Blood|April 23, 2020
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 studyCorentin Orvain, Marie Balsat, Emmanuelle Tavernier, et al.
Bone Marrow Transplantation|October 13, 2020
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMTLeyre Bento, Ariane Boumendil, Hervé Finel, et al.
Blood|March 29, 2003
Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemiaEric Solary, Bernard Drenou, Lydia Campos, et al.
Leukemia & Lymphoma|April 5, 2018
Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phaseLise-Marie Mollard, Aurélie Chauveau, Françoise Boyer-Perrard, et al.
British Journal of Haematology|June 19, 2013
Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-HématologiqueMichael Darmon, François Vincent, Laurent Camous, et al.
American Journal of Hematology|March 25, 2023
Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scoresAmélie Bachelot, Anne Bouvier, Jérémie Riou, et al.
Haematologica|October 26, 2010
A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 studyMathilde Hunault-Berger, Thibaut Leguay, Xavier Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMSArnaud Pigneux, Jean-Luc Harousseau, Francis Witz, et al.
Journal of the American Academy of Dermatology|February 10, 2019
Abnormal T-cell phenotype in episodic angioedema with hypereosinophilia (Gleich syndrome): Frequency, clinical implication, and prognosisNoémie Abisror, Arsène Mekinian, Agnès Dechartres, et al.
Pageof 13